©The Author(s) 2026.
World J Methodol. Mar 20, 2026; 16(1): 108178
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.108178
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.108178
Table 1 Demographic characteristics of group I and group II, n (%)/mean ± SD
| Demographic characteristics | Group I (n = 92) | Group II (n = 81) | P value |
| Age, in years | 52.26 ± 10.12 | 53.49 ± 9.96 | 0.422 |
| Male | 81 (89) | 69 (85) | 0.2021 |
| Female | 11 (11) | 12 (14) | |
| Non-vegetarian diet | 72 (78) | 59 (72) | 0.5671 |
| Smokers | 62 (67) | 48 (59) | 0.4941 |
| Alcohol consumption | 26 (28) | 10 (12) | 0.1141 |
| Tobacco chewer | 44 (47) | 31 (38) | 0.4041 |
| Hypertensive | 38 (41) | 28 (31) | 0.4081 |
| Diabetic | 49 (53) | 38 (47) | 0.6921 |
Table 2 Comparison of biochemical parameters of group I and group II, mean ± SD
| Biochemical profile | Group I (n = 92) | Group II (n = 81) | P value |
| Total Cholesterol (mg/dL) | 136.2 ± 39.6 | 144.2 ± 62.0 | 0.836 |
| Triglycerides (mg/dL) | 152.7 ± 136.4 | 159.2 ± 100.7 | 0.211 |
| HDL (mg/dL) | 38.4 ± 18.4 | 36.6 ± 12.2 | 0.999 |
| LDL (mg/dL) | 72.1 ± 34.0 | 78.8 ± 47.6 | 0.705 |
| VLDL (mg/dL) | 30.5 ± 27.3 | 31.6 ± 20.1 | 0.250 |
| Hemoglobin (g/dL) | 13.8 ± 2.0 | 13.8 ± 2.0 | 0.565 |
| WBC (cells/µL) | 10845.2 ± 5312.3 | 10043.5 ± 7036.5 | 0.009 |
| Neutrophils (cells/µL) | 7203.4 ± 4224.8 | 6158.2 ± 4060.2 | 0.007 |
| Lymphocytes (cells/µL) | 3489.4 ± 1818.1 | 2454.6 ± 1091.3 | 0.001 |
| Monocytes (cells/µL) | 733.1 ± 639.0 | 620.9 ± 409.7 | 0.103 |
| Eosinophils (cells/µL) | 327.5 ± 383.9 | 363.8 ± 565.2 | 0.543 |
| NHR | 223.8 ± 146.9 | 199.7 ± 149.4 | 0.042 |
Table 3 Echocardiography parameters of Group I and Group II
| Echocardiography parameters | Group I | Group II | P value |
| Anterior wall myocardial infarction | 50 (54%) | 21 (25%) | 0.14 |
| Inferior wall myocardial infarction | 28 (30%) | 6 (12%) | |
| Normal LV systolic function | 1 (1%) | 72 (88%) | 0.001 |
| Mild LV systolic dysfunction | 26 (28%) | 5 (6%) | |
| Moderate LV systolic dysfunction | 32 (34%) | 2 (2%) | |
| Severe LV systolic dysfunction | 33 (35%) | 2 (2%) | |
| LVEF | 34.83 ± 5.1 | 59.38 ± 2.2 | 0.001 |
Table 4 Regression analysis between left ventricular ejection fraction and blood components
| Parameters | R2 | P value |
| WBCs | 0.007 | 0.237 |
| Neutrophils | 0.019 | 0.051 |
| Lymphocytes | 0.089 | 0.001 |
| NHR | 0.013 | 0.111 |
Table 5 Receiver operating characteristic curve analysis for prediction for reduced left ventricular ejection fraction
| Area under curve (95%CI) | Sensitivity | Specificity | P value | |
| WBC | 0.61 (0.53-0.70) | 72% | 60% | 0.009 |
| Neutrophils | 0.61 (0.53-0.71) | 56% | 60% | 0.007 |
| Lymphocytes | 0.68 (0.61-0.76) | 72% | 60% | 0.001 |
| NHR | 0.59 (0.50-0.67) | 65% | 52% | 0.04 |
- Citation: Dabla PK, Shrivastav D, Mehta V, Singh S, Mir R. White blood cells and neutrophil-to-high density lipoprotein ratio as predictive markers of left ventricular dysfunction in heart failure. World J Methodol 2026; 16(1): 108178
- URL: https://www.wjgnet.com/2222-0682/full/v16/i1/108178.htm
- DOI: https://dx.doi.org/10.5662/wjm.v16.i1.108178
